Grants and Contributions:
Title:
207583
Agreement Number:
207583
Agreement Value:
$2,803,148.00
Agreement Date:
Mar 20, 2017 - Dec 31, 2018
Description:
Develop a liquid oral suspension for metronidazole
Organization:
Atlantic Canada Opportunities Agency
Location:
Halifax, Nova Scotia, CA B3H 0A8
Reference Number:
276-2016-2017-Q4-00171
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Additional Information:
The assistance type is Conditionally Repayable Contribution.
Recipient's Legal Name:
Appili Therapeutics Inc.
Program:
Atlantic Innovation Fund (AIF) - II